Objective:

To identify potential genetic biomarkers that can differentiate rheumatoid arthritis (RA) from osteoarthritis (OA).

Approach:

Key Findings:

• EPYC, MAGED1, and LAP3 are potential biomarkers for distinguishing RA from OA.
• Diagnostic performance of the identified genes was strong, with AUC values above 0.85.
• The support vector machine model achieved approximately 93% accuracy.

Interpretation:

The findings suggest that the identified genes may reflect immune activity in joint tissue, aiding in the differentiation of RA from OA.

Limitations:

• Small sample sizes and reliance on cross-sectional transcriptomic data limit causation establishment.
• Experimental validation was restricted to messenger RNA expression in a single cell model.
• Drug sensitivity analyses were based on cancer cell data, which may not accurately represent RA responses.

Conclusion:

Further validation in independent clinical cohorts and mechanistic studies is necessary before clinical application of these biomarkers.

Sources:

• Frontiers in Medicine
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.